Back    Zoom +    Zoom -
PA GOODDOCTOR Rallies 9%+ as 2025 NP Spikes 3.66x to RMB380M, Beating Forecast
Recommend
4
Positive
13
Negative
4
PA GOODDOCTOR (01833.HK) opened 4% higher at $11.96 today (25th), and once surged 10.8% to a high of $12.74 in the morning session. It last printed at $12.63, hyping up 9.83%, with a trading volume of 6.6516 million shares, involving $82.5524 million.

The Group's 2025 turnover was RMB5.468 billion, up 13.7% YoY. During the period, gross profit amounted to RMB1.772 billion, up 16.3% YoY. Net profit was RMB380 million, up 366.1% YoY, with an EPS of RMB0.18. Adjusted net profit rose by 161.3% to RMB414 million.

Related NewsCiti: PA GOODDOCTOR (01833.HK) Rated at Buy w/ TP $18 as 2025 NP Beats
PA GOODDOCTOR’s 2025 revenue was in line with expectation, while its net profit beat the forecasts of both the market/ Citi Research, Citi Research issued a research report saying. Therefore, the broker rated PA GOODDOCTOR at Buy, with a target price of $18.
AAStocks Financial News
Website: www.aastocks.com